| Dr Dustin D Davis, DO | |
|
201 W Market St, Georgetown, DE 19947-1440 | |
| (302) 856-2254 | |
| (302) 856-2330 |
| Full Name | Dr Dustin D Davis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 201 W Market St, Georgetown, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417044157 | NPI | - | NPPES |
| 0001044304 | Medicaid | DE | |
| C2-0006044 | Other | DE | ST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | C2-0006044 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beebe Medical Center | Lewes, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Nanticoke Memorial Hospital | Seaford, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rehabclinics Spt Inc | 7113834102 | 298 |
| Georgetown Family Medicine | 8123008471 | 2 |
News Archive
Mylan Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets (OTC), 5 mg and 10 mg.
The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with TransGenex Nanobiotech, Inc., a company that is developing nano-scale technologies for novel, cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases.
A cross-disciplinary team of scientists, led by University of Massachusetts Amherst environmental epigeneticist Richard Pilsner, will use a three-year, $1.6 million grant from the National Institute of Environmental Health Sciences to expand research into the impact of phthalate exposure on male fertility.
A new study finds that exposure to a chemical component of diesel exhaust particles can compromise the ability of resistance arteries to regulate blood flow to bone marrow.
Oncolytics Biotech has announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.
› Verified 7 days ago
| Entity Name | Georgetown Family Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225173149 PECOS PAC ID: 8123008471 Enrollment ID: O20040726000726 |
News Archive
Mylan Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets (OTC), 5 mg and 10 mg.
The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with TransGenex Nanobiotech, Inc., a company that is developing nano-scale technologies for novel, cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases.
A cross-disciplinary team of scientists, led by University of Massachusetts Amherst environmental epigeneticist Richard Pilsner, will use a three-year, $1.6 million grant from the National Institute of Environmental Health Sciences to expand research into the impact of phthalate exposure on male fertility.
A new study finds that exposure to a chemical component of diesel exhaust particles can compromise the ability of resistance arteries to regulate blood flow to bone marrow.
Oncolytics Biotech has announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dustin D Davis, DO 201 W Market St, Georgetown, DE 19947-1440 Ph: (302) 856-2254 | Dr Dustin D Davis, DO 201 W Market St, Georgetown, DE 19947-1440 Ph: (302) 856-2254 |
News Archive
Mylan Inc. has announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets (OTC), 5 mg and 10 mg.
The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with TransGenex Nanobiotech, Inc., a company that is developing nano-scale technologies for novel, cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases.
A cross-disciplinary team of scientists, led by University of Massachusetts Amherst environmental epigeneticist Richard Pilsner, will use a three-year, $1.6 million grant from the National Institute of Environmental Health Sciences to expand research into the impact of phthalate exposure on male fertility.
A new study finds that exposure to a chemical component of diesel exhaust particles can compromise the ability of resistance arteries to regulate blood flow to bone marrow.
Oncolytics Biotech has announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.
› Verified 7 days ago
Dr. Eileen Mary Davis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 W Market St, Georgetown, DE 19947 Phone: 302-856-2254 Fax: 302-856-2330 | |
Joseph Francis Karnish, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 W Market St, Suite 110, Georgetown, DE 19947 Phone: 302-856-7099 Fax: 302-856-3247 | |
Lisa Bartels, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21635 Biden Ave, Georgetown, DE 19947 Phone: 302-856-9596 Fax: 302-645-4744 | |
Dr. Judy L. Bailey, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 26351 Patriots Way, Georgetown, DE 19947 Phone: 302-933-3000 Fax: 302-934-1145 | |
Lorren Michael Donmoyer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21635 Biden Ave, Georgetown, DE 19947 Phone: 302-856-9596 |